Published in Adv Pharmacol Sci on December 17, 2012
'FREEDOM' trial: have the interventional cardiologists lost their freedom? Indian Heart J (2013) 0.75
Recovery of Left Ventricular Function After Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Grafting in Patients with Multi-Vessel Coronary Disease and Left Ventricular Dysfunction. Hawaii J Med Public Health (2016) 0.75
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1996) 6.70
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med (2007) 5.37
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet (2003) 4.68
Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol (2001) 4.50
Coronary-artery stents. N Engl J Med (2006) 4.13
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med (2007) 3.84
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J (2011) 3.29
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med (2007) 2.91
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol (2011) 2.85
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med (2011) 2.65
A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med (1997) 2.57
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation (2010) 2.54
Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol (2005) 2.50
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation (2009) 2.40
Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med (2006) 2.38
Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation (2008) 2.26
Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol (2010) 2.24
Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients. Circulation (2006) 2.24
Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation (2004) 1.86
Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol (2005) 1.77
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial. Catheter Cardiovasc Interv (2011) 1.71
5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials. JACC Cardiovasc Interv (2011) 1.62
Stent thrombosis redux--the FDA perspective. N Engl J Med (2007) 1.60
Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol (2010) 1.51
Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical Center-Multivessel Revascularization Registry. J Am Coll Cardiol (2011) 1.49
Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients. Eur J Cardiothorac Surg (2009) 1.47
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. EuroIntervention (2006) 1.46
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial. J Am Coll Cardiol (2006) 1.30
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol (2010) 1.21
Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention (2012) 1.12
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J (2008) 1.11
Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial. Am J Cardiovasc Drugs (2006) 0.94
Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med (2007) 0.92
Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease. Am J Cardiol (2010) 0.90
Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J (2007) 0.88
Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications. J Am Coll Cardiol (2009) 0.87
Revascularization interventions for ischemic heart disease. Curr Opin Cardiol (2000) 0.80
Effectiveness and cost-effectiveness of coronary artery bypass surgery versus drug eluting stents in Armenia: a feasibility study. Georgian Med News (2011) 0.79
Cost-effectiveness of drug-eluting stents. Hellenic J Cardiol (2006) 0.76
Bioresorbable stents: the next revolution. Circulation (2010) 0.76
Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)? Circulation (2004) 0.76
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol (2006) 2.68
Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol (2004) 2.36
Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma (2009) 1.56
Postoperative complications of salvage total laryngectomy. Cancer (2005) 1.53
Developments in technique and technology: the effect on the results of percutaneous nephrolithotomy for staghorn calculi. BJU Int (2009) 1.41
Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome. Cancer (2011) 1.37
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer (2009) 1.30
Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res (2011) 1.28
A failure to communicate: a qualitative exploration of care coordination between hospitalists and primary care providers around patient hospitalizations. J Gen Intern Med (2014) 1.22
Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer (2006) 1.19
Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions. Integr Biol (Camb) (2013) 1.10
Molecular profiling of tumor progression in head and neck cancer. Arch Otolaryngol Head Neck Surg (2005) 1.10
Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid (2009) 1.07
Prognostic factors for malignant melanoma of the squamous mucosa of the head and neck. Am J Surg Pathol (2002) 1.01
Implant prosthodontic rehabilitation of fibula free-flap reconstructed mandibles: a Memorial Sloan-Kettering Cancer Center review of prognostic factors and implant outcomes. Int J Oral Maxillofac Implants (2005) 0.99
The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. Surgery (2011) 0.97
Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head Neck (2002) 0.93
A systematic review of patient-reported outcome measures in head and neck cancer surgery. Otolaryngol Head Neck Surg (2007) 0.93
Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol (2009) 0.92
Microvascular reconstruction of the skull base: a clinical approach to surgical defect classification and flap selection. Skull Base (2007) 0.91
Isocapnic hyperpnea training improves performance in competitive male runners. Eur J Appl Physiol (2007) 0.88
Sialadenosis associated with diabetes mellitus: a case report. J Oral Maxillofac Surg (2002) 0.87
Comparative evaluation of adverse drug reaction reporting forms for introduction of a spontaneous generic ADR form. J Pharmacol Pharmacother (2012) 0.86
Outcome of ligation of the inferior vena cava in the modern era. Am J Surg (2010) 0.86
Measuring quality of life in dysphonic patients: a systematic review of content development in patient-reported outcomes measures. J Voice (2009) 0.83
Analysis of failure in patients with adenoid cystic carcinoma of the head and neck. An international collaborative study. Head Neck (2013) 0.82
Outcomes of primary and secondary tracheoesophageal puncture: a 16-year retrospective analysis. Ear Nose Throat J (2006) 0.82
A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2013) 0.82
Management of oral and oropharyngeal cancers. Oral Dis (2003) 0.77
Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer. Ann Surg Oncol (2014) 0.77
Prosthetic intervention in the era of microvascular reconstruction of the mandible--a retrospective analysis of functional outcome. Int J Prosthodont (2005) 0.77
Expression of S100 Protein in CD4-positive T-cell Lymphomas Is Often Associated With T-cell Prolymphocytic Leukemia. Am J Surg Pathol (2015) 0.77
Flexible CO2 laser and submucosal gel injection for safe endoluminal resection in the intestines. Surg Endosc (2011) 0.75
Pharmacoeconomics of Surgical Interventions vs. Cyclooxygenase Inhibitors for the Treatment of Patent Ductus Arteriosus. J Pediatr Pharmacol Ther (2007) 0.75
Clinical and histopathologic examination of ulcerating vocal fold lesions in an immunosuppressed patient. Am J Otolaryngol (2009) 0.75
Health-Related Quality of Life following Reconstruction for Common Head and Neck Surgical Defects. Plast Reconstr Surg (2016) 0.75
The evolving role of glycoprotein (GP) IIb/IIIa receptor blockade during percutaneous coronary intervention of saphenous vein bypass grafts. J Invasive Cardiol (2004) 0.75
Parafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas. Appl Immunohistochem Mol Morphol (2016) 0.75
EMS Dispatches during Hurricanes Irene and Sandy in New Jersey. Prehosp Emerg Care (2017) 0.75